Cerus (NSDQ:CERS) said today that the 1st patient was transfused in Puerto Rico in a clinical trial comparing red blood cells processed with its Intercept blood system to conventional red blood cells. Concord, Calif.-based Cerus is developing the Intercept blood system, a pathogen reduction device designed to inactivate a broad range of viruses, bacteria, parasites […]
Cerus Corp.
Cerus lands $47m for Intercept red blood cell system
Cerus (NSDQ:CERS) said today that it exercised $46.6 million in additional options from its contract with the Biomedical Advanced Research & Development Authority, a part of the U.S. Dept. of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response. Concord, Calif.-based Cerus is developing the Intercept blood system, a pathogen reduction device designed […]
Cerus shares fall after Q1 miss
Shares in Cerus Corp. (NSDQ:CERS) fell -18% today after the company missed expectations on Wall Street with its 1st quarter results. The Concord, Calif.-based company posted a net loss of -$18.7 million, or -18¢ per share, on sales of $7 million for the 3 months ended March 31, for bottom-line loss of -10.7% on sales growth of […]
Cerus raises funds for phase III trial of Intercept red blood cell system
Cerus Corporation (NSDQ:CERS) said today that it exercised $10.8 million in additional options from its contract with the Biomedical Advanced Research & Development Authority, a part of the U.S. Dept. of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response. The funds will go towards in vitro pathogen inactivation and red blood cell […]
Seno Medical grabs ex-CeloNova CFO Davis | Personnel Moves August 12, 2016
Seno Medical grabs ex-CeloNova CFO Davis Seno Medical Instuments said this week it tapped former CeloNova BioSciences chief financial officer Eric Davis to take over the CFO role at Seno Medical. Prior to his years at CeloNova, Davis operated as CFO and operating officer at Genesis Networks Enterprises. Seno Medical said that Davis has more than […]
UPDATE: Cerus, Terumo land $48m in BARDA grants for anti-Zika push
Updated with comments from Terumo. Cerus (NSDQ: CERS) and Terumo Corp. (TYO:4543) won grants from a U.S. Health & Human Services Dept. agency worth a collective $48 million to study their respective devices for eliminating blood pathogens like the Zika virus. Zika, which the World Health Organization declared a global emergency in February, has been linked to microcephaly, a birth […]
Cerus wins Health Canada approval for Intercept blood system
Cerus Corp. (NSDQ: CERS) said today it won Health Canada approval for its Intercept blood system designed to reduce the risk of transfusion-transmitted infections in blood plasma. The Concord, Calif.-based company said the system is now cleared in Canada to be used for the ex vivo preparation of pathogen-reduced, whole blood derived or apheresis plasma to reduce the […]
Cerus inks supply deal with Red Cross
Cerus Corp. (NSDQ: CERS) said this week that the American Red Cross inked a multi-year purchase agreement for its Intercept blood system designed to reduce the risk of transfusion-transmitted infections in blood plasma and platelets. The American Red Cross is the largest supplier of blood products in the U.S., collecting and processing approximately 40% of the blood […]
GI Dynamics axes medical chief Maggs | Personnel Moves
GI Dynamics (ASX:GID) said last week in a regulatory filing that it fired chief medical officer Dr. David Maggs “for cause.” The Lexington, Mass.-based medical device company did not otherwise elaborate on the reason for Maggs’s departure, which was effective June 18, according to the filing. Maggs joined GI Dynamics in April 2013 to oversee the clinical […]